Lataa...
Long-term oral antiarrhythmic therapy with mexiletine.
Forty-eight patients with ischaemic heart disease received oral mexiletine for the control or prevention of ventricular arrhythmias. The most frequently used doses were 200, 250, and 300 mg 8-hourly. The treatment period varied from 2 days to more than 1 year (median 3 months). No ventricular arrhyt...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1978
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC483486/ https://ncbi.nlm.nih.gov/pubmed/687477 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|